Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients

Journal of Clinical Oncology

Volumn 9, Issue 11, 1991, Pages 2021-2026

  Platanias, Leonidas C ^a   Miller, Carole B ^b   Mick, Rosemarie ^b   Hart, Ronald D ^b   Ozer, Howard ^b   McEvilly, Jan Marie ^b   Jones, Richard J ^b   Ratain, Mark J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMAN; INJECTIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025951612     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.11.2021     Document Type: Article

References (22)

1. Dainiak N, Kulkani V, Howard D, et al: Mechanisms of abnormal erythropoiesis in malignancy. Cancer 51:1101-1106, 1983
2. Williams WJ, Beutler E, Erslev AJ, et al: Hematology, 3rd ed. New York, NY, McGraw-Hill, 1983
3. Gale RP: Antineoplastic chemotherapy myelosuppression: Mechanisms and new approaches. Exp Hematol 13: 3-7, 1985 (suppl 16)
4. Lelieveld P, Van Der Vijgh WJF, Veldhuizen RW, et al: Preclinical studies on toxicity, antitumor activity and pharmacokinetics of cisplatin and three recently developed derivatives. Eur J Clin Oncol 20:1087-1104, 1984
5. Rothmann SA, Paul P, Weick JK, et al: Effect of cis-diamminedichloroplatinum on erythropoietin production and hematopoietic progenitor cells. Int J Cell Cloning 3:415-423, 1985
6. Miller CB, Jones RJ, Piantadosi S, et al: Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689-1692, 1990
7. Spivak JL: The mechanisms of action of erythropoietin. Int J Cell Cloning 4:139-166, 1986
8. Winearls CG, Oliver DO, Pippard MJ, et al: Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic hemodialysis. Lancet 2:1175-1178, 1986
9. Eschbach JW, Egrie JC, Downing MR, et al: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a phase 1 and II clinical trial. N Engl J Med 316:73-78, 1987
10. Lim VS, DeGowin RL, Zavala D, et al: Recombinant human erythropoietin treatment in predialysis patients. A double-blind placebo-controlled trial. Ann Intern Med 110:108-114, 1989
11. Pincus T, Olsen NJ, Russell J, et al: Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89:161-168, 1990
12. Ludwig H, Fritz E, Kotzman, et al: Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322:1693-1699, 1990
13. Fishl M, Galpin JE, Levine JD, et al: Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322:1488-1493, 1990
14. Oster W, Herrmann F, Gamm H, et al: Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 8:956-962, 1990
15. Matsumoto T, Endoh K, Kamisango K, et al: Effect of recombinant human erythropoietin on anticancer druginduced anemia. Br J Haematol 75:463-468, 1990
16. Miller CB, Platanias LC, Ratain MJ, et al: A phase I/II trial of erythropoietin (Epo) in the treatment of chemotherapy-induced anemia in patients with cancer. Proc Am Soc Clin Oncol 9:194, 1990 (abstr)
17. Armitage P: Test for linear trend in proportions and frequencies. Biometrics 11:375-386, 1955
18. Cox DR: The analysis of binary data. London, UK, Methuen & Co, 1970
19. Baer AN, Dessypris EN, Goldwasser E, et al: Blunted erythropoietin response to anemia in rheumatoid arthritis. Br J Haematol 66:553-564, 1987
20. Hochberg MC, Arnold CM, Hogans BB, et al: Serum erythropoietin in rheumatoid arthritis: Impaired response to anemia. Arthritis Rheum 31:1318-1321, 1988
21. Spivak JL, Barnes DC, Fuchs E, et al: Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 261:3104-3107, 1989
22. Ireland RM, Atkinson K, Concannon A, et al: Serum erythropoietin change in autologous and allogeneic bone marrow transplant patients. BrJ Haematol 76:128-134, 1990